ATF3 and inflammatory bowel disease: In our mouse model, Atf3 expression in colon was increased by evacetrapib treatment but decreased in CETP-Tg mice, suggesting HDL-C improves IBD severity via inducing ATF3 and promoting an anti-inflammatory macrophages reprogramming.